Finerenone in Persons with Chronic Kidney Disease without Diabetes
New England Journal of Medicine · 06.08.2026 · 395 (6) · 533-545
DOI: 10.1056/nejmoa2604625 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 06.08.2026. Verfasst von Hiddo J L Heerspink und 18 weiteren Autor:innen. Beteiligte Einrichtung: George Institute for Global Health, University of New South Wales, Sydney. Hauptthemen laut MEDLINE: Albuminuria, Cardiovascular Diseases, Naphthyridines, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Bayer AG.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- George Institute for Global Health, University of New South Wales, Sydney.
- Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- Department of Renal Medicine, Royal North Shore Hospital, Sydney.
- Division of Nephrology, Richard L. Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis.
- Division of Nephrology, University Health Network, Toronto General Hospital, University of Toronto, Toronto.
- National Heart Centre Singapore, Singapore.
ORCID-Profile: Hiddo J L Heerspink, Rajiv Agarwal, Katherine R Tuttle, Nicole Rethemeier
Förderung
- Bayer AG
Zitieren
APA
Heerspink, H. J. L., Neuen, B. L., Agarwal, R., Cherney, D. Z. I., Lam, C. S. P., Tuttle, K. R., Wanner, C., Sarafidis, P., Jongs, N., Smeijer, J. D., Brinker, M., Rethemeier, N., Schloemer, P., Vesterinen, P., Goldsbury, D., Dizayee, S., Mares, J. W., Perkovic, V., & FIND-CKD Investigators (2026). Finerenone in Persons with Chronic Kidney Disease without Diabetes. New England Journal of Medicine, 395(6), 533-545. https://doi.org/10.1056/nejmoa2604625
Vancouver
Heerspink HJL, Neuen BL, Agarwal R, Cherney DZI, Lam CSP, Tuttle KR, et al. Finerenone in Persons with Chronic Kidney Disease without Diabetes. New England Journal of Medicine. 2026;395(6):533-545. doi:10.1056/nejmoa2604625
BibTeX
@article{Heerspink2026,
author = {Heerspink, Hiddo J L and Neuen, Brendon L and Agarwal, Rajiv and Cherney, David Z I and Lam, Carolyn S P and Tuttle, Katherine R and Wanner, Christoph and Sarafidis, Pantelis and Jongs, Niels and Smeijer, J David and Brinker, Meike and Rethemeier, Nicole and Schloemer, Patrick and Vesterinen, Paula and Goldsbury, David and Dizayee, Sara and Mares, Jon W and Perkovic, Vlado and FIND-CKD Investigators, FIND-CKD Investigators},
title = {Finerenone in Persons with Chronic Kidney Disease without Diabetes},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {6},
pages = {533--545},
doi = {10.1056/nejmoa2604625}
}
EUVIMED